Published Date: 30-Sep-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Bariatric Surgery Devices Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 5.3% CAGR during the forecast period.
The Minimally Invasive Surgical Devices market acquired the maximum revenue share in the Global Bariatric Surgery Devices Market by Devices Type in 2021, thereby, achieving a market value of $1.9 billion by 2028. Because they require fewer, smaller incisions and are consequently less painful, minimally invasive or bariatric surgery techniques are preferred usually over open weight reduction surgery methods. Additionally, they are linked to a quicker recovery and notably decreased incidence of complications and mortality.
The Biliopancreatic Diversion with Duodenal Switch (BPD/DS) market is showcasing a CAGR of 7.9% during (2022 - 2028). There are two elements to the Biliopancreatic Diversion with Duodenal Switch (BPD/DS). First, a tube-shaped pouch is made out of a part of the stomach (identical to sleeve gastrectomy). Second, the small intestine is largely bypassed. This limits the amount of food the patient's stomach can retain and expedites the process of feeling full.
The North America market dominated the Global Bariatric Surgery Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $888.2 million by 2028. The Europe market is estimated to witness a CAGR of 4.8% during (2022 - 2028). Additionally, The Asia Pacific market would generate a CAGR of 5.8% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson & Johnson, ReShape Lifesciences, Inc., Apollo Endosurgery, Inc., Medtronic PLC, Olympus Corporation, Intuitive Surgical, Inc., B. Braun Melsungen AG, Spatz FGIA, Inc., Cook Medical, Inc. (Cook Group), and Richard Wolf GmbH.
By Devices Type
Unique Offerings from KBV Research